{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:29:02Z","timestamp":1768084142023,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T00:00:00Z","timestamp":1372377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-293","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T08:14:13Z","timestamp":1372407253000},"source":"Crossref","is-referenced-by-count":15,"title":["Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study"],"prefix":"10.1186","volume":"13","author":[{"given":"Eric","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Bernard","family":"Ruidavets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Genoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Mabile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Busato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Obadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Pr\u00e9voteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Marchou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Massip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Marion-Latard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Delpierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Perret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,28]]},"reference":[{"key":"2511_CR1","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","volume":"354","author":"K Brinkman","year":"1999","unstructured":"Brinkman K, Smeitink JA, Romijn JA, Reiss P: Mitochondrial toxicity induced by nucleoside-analogue reversetranscriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet. 1999, 354: 1112-1115. 10.1016\/S0140-6736(99)06102-4.","journal-title":"Lancet"},{"key":"2511_CR2","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","volume":"50","author":"M Caron","year":"2001","unstructured":"Caron M, Auclair M, Vigouroux C, Glorian M, Forest C, Capeau J: The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes. 2001, 50: 1378-1388. 10.2337\/diabetes.50.6.1378.","journal-title":"Diabetes"},{"key":"2511_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","volume":"17","author":"D Bruera","year":"2003","unstructured":"Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J: Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS. 2003, 17: 1917-1923. 10.1097\/00002030-200309050-00010.","journal-title":"AIDS"},{"key":"2511_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","volume":"16","author":"M Yin","year":"2005","unstructured":"Yin M, Dobkin J, Brudney K, et al: Bone mass and mineral metabolism in HIV\u2009+\u2009postmenopausal women. Osteoporos Int. 2005, 16: 1345-1352. 10.1007\/s00198-005-1845-0.","journal-title":"Osteoporos Int"},{"key":"2511_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","volume":"22","author":"C Cazanave","year":"2008","unstructured":"Cazanave C, Dupon M, Lavignolle-Aurillac V, et al: Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS. 2008, 22: 395-402. 10.1097\/QAD.0b013e3282f423dd.","journal-title":"AIDS"},{"key":"2511_CR6","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1210\/jc.2008-0828","volume":"93","author":"VA Triant","year":"2008","unstructured":"Triant VA, Brown TT, Lee H, Grinspoon SK: Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008, 93: 3499-3504. 10.1210\/jc.2008-0828.","journal-title":"J Clin Endocrinol Metab"},{"key":"2511_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/jinf.2002.1109","volume":"46","author":"J Teichmann","year":"2003","unstructured":"Teichmann J, Stephan E, Lange U, et al: Osteopenia in HIVinfected women prior to highly active antiretroviral therapy. J Infect. 2003, 46: 221-227. 10.1053\/jinf.2002.1109.","journal-title":"J Infect"},{"key":"2511_CR8","first-page":"39","volume":"48","author":"G Madeddu","year":"2004","unstructured":"Madeddu G, Spanu A, Solinas P, et al: Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging. 2004, 48: 39-48.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2511_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/aid.2006.22.125","volume":"22","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Smith B, Weaver M, et al: Ethnic variations in the prevalence of metabolic bone disease among HIVpositive patients with lipodystrophy. AIDS Res Hum Retroviruses. 2006, 22: 125-131. 10.1089\/aid.2006.22.125.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2511_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/aid.2008.0183","volume":"25","author":"M Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez M, Daniels B, Gunawardene S, Robbins GK: High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses. 2009, 25: 9-14. 10.1089\/aid.2008.0183.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2511_CR11","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1097\/00002030-200110190-00018","volume":"15","author":"D Nolan","year":"2001","unstructured":"Nolan D, Mallal S: Getting to the HAART of insulin resistance. AIDS. 2001, 15: 2037-2041. 10.1097\/00002030-200110190-00018.","journal-title":"AIDS"},{"key":"2511_CR12","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1210\/jc.2006-0127","volume":"91","author":"SE Dolan","year":"2006","unstructured":"Dolan SE, Kanter JR, Grinspoon S: Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab. 2006, 91: 2938-2945. 10.1210\/jc.2006-0127.","journal-title":"J Clin Endocrinol Metab"},{"key":"2511_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1385\/JCD:8:3:287","volume":"8","author":"E Bonnet","year":"2005","unstructured":"Bonnet E, Delpierre C, Sommet A, et al: Total body composition by DXA of 241 HIVnegative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom. 2005, 8: 287-292. 10.1385\/JCD:8:3:287.","journal-title":"J Clin Densitom"},{"key":"2511_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, 903 Study Group, et al: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004, 292: 191-201. 10.1001\/jama.292.2.191.","journal-title":"JAMA"},{"key":"2511_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","volume":"23","author":"C Duvivier","year":"2009","unstructured":"Duvivier C, Kolta S, Assoumou L, et al: ANRS 121 Hippocampe study group. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS. 2009, 23: 817-824.","journal-title":"AIDS"},{"key":"2511_CR16","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/QAD.0b013e32832ce85a","volume":"23","author":"M Borderi","year":"2009","unstructured":"Borderi M, Gibellini D, Vescini F, et al: Metabolic bone disease in HIV infection. AIDS. 2009, 23: 1297-1310. 10.1097\/QAD.0b013e32832ce85a.","journal-title":"AIDS"},{"key":"2511_CR17","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB: Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006, 20: 2165-2174. 10.1097\/QAD.0b013e32801022eb.","journal-title":"AIDS"},{"key":"2511_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1359\/JBMR.0301246","volume":"19","author":"C Amiel","year":"2004","unstructured":"Amiel C, Ostertag A, Slama L, et al: BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res. 2004, 19: 402-409.","journal-title":"J Bone Miner Res"},{"key":"2511_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jocd.2007.07.006","volume":"10","author":"C Delpierre","year":"2007","unstructured":"Delpierre C, Bonnet E, Marion-Latard F, et al: Impact of HIV infection on total body composition in treatment- naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls. J Clin Densitom. 2007, 10: 376-380. 10.1016\/j.jocd.2007.07.006.","journal-title":"J Clin Densitom"},{"key":"2511_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3748\/wjg.v11.i12.1843","volume":"11","author":"I Schiefke","year":"2005","unstructured":"Schiefke I, Fach A, Wiedmann M, et al: Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005, 11: 1843-1847.","journal-title":"World J Gastroenterol"},{"key":"2511_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","volume":"5","author":"TT Brown","year":"2009","unstructured":"Brown TT, McComsey GA, King MS, Qaqish RB, Bernstein BM, Da Silva BA: Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr. 2009, 5: 554-561.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2511_CR22","doi-asserted-by":"publisher","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P Tebas","year":"2006","unstructured":"Tebas P, Powde rly WG, Claxton S, et al: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2006, 14: F63-F67.","journal-title":"AIDS"},{"key":"2511_CR23","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"GA McComsey","year":"2011","unstructured":"McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, Sax PE: Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: aids clinical trials group A5224s, a substudy of ACTG A5202. J Infect Dis. 2011, 203: 1791-1801. 10.1093\/infdis\/jir188.","journal-title":"J Infect Dis"},{"key":"2511_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-011-0099-z","volume":"9","author":"I Ofotokun","year":"2012","unstructured":"Ofotokun I, McIntosh E, Weitzmann MN: HIV: inflammation and bone. Curr HIV\/AIDS Rep. 2012, 9: 16-25. 10.1007\/s11904-011-0099-z.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2511_CR25","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/00002030-200109280-00011","volume":"15","author":"S Mora","year":"2001","unstructured":"Mora S, Sala N, Bricalli D, Zuin G, Chiumello G, Vigan\u00f2 A: Bone mineral loss through increased bone turnover in HIVinfected children treated with highly active antiretroviral therapy. AIDS. 2001, 15: 1823-1829. 10.1097\/00002030-200109280-00011.","journal-title":"AIDS"},{"key":"2511_CR26","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1210\/jc.2003-031113","volume":"89","author":"S Mora","year":"2004","unstructured":"Mora S: Relationship of sex hormones to bone geometric properties and mineral density in early pubertal girls: use of correlation analyses. J Clin Endocrinol Metab. 2004, 89: 1698-1703. 10.1210\/jc.2003-031113.","journal-title":"J Clin Endocrinol Metab"},{"key":"2511_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1468-1293.2005.00278.x","volume":"6","author":"E Seminari","year":"2005","unstructured":"Seminari E, Castagna A, Soldarini A, et al: Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. HIV Med. 2005, 6: 145-150. 10.1111\/j.1468-1293.2005.00278.x.","journal-title":"HIV Med"},{"key":"2511_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1196\/annals.1346.057","volume":"1068","author":"G Pan","year":"2006","unstructured":"Pan G, Yang Z, Ballinger SW, McDonald JM: Pathogenesis of osteopenia\/osteoporosis induced by highly active antiretroviral therapy for AIDS. Ann N Y Acad Sci. 2006, 1068: 297-308. 10.1196\/annals.1346.057.","journal-title":"Ann N Y Acad Sci"},{"key":"2511_CR29","doi-asserted-by":"publisher","first-page":"48251","DOI":"10.1074\/jbc.M304676200","volume":"278","author":"JM Fakruddin","year":"2003","unstructured":"Fakruddin JM, Laurence J: HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma\/RANKL cross-talk. J Biol Chem. 2003, 278: 48251-48258. 10.1074\/jbc.M304676200.","journal-title":"J Biol Chem"},{"key":"2511_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature03398","volume":"434","author":"F Elefteriou","year":"2005","unstructured":"Elefteriou F, Ahn JD, Takeda S, et al: Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005, 434: 514-520. 10.1038\/nature03398.","journal-title":"Nature"},{"key":"2511_CR31","volume-title":"BMC Endocrinol Disord","author":"V Arama","year":"2013","unstructured":"Arama V, Tiliscan C, Streinu-Cercel A, Ion F, Mihailescu R, Munteanu D, Hristea A, Arama SS: SLD-ART study group. Insulin resistance and adipokines serum levels in a Caucasian cohort of HIV-positive patients undergoing antiretroviral therapy: a cross-sectional study. BMC Endocrinol Disord. 2013, 13: 1186\/1472-6823-13-14."},{"key":"2511_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1742-6405-7-40","volume":"7","author":"A Conesa-Botella","year":"2010","unstructured":"Conesa-Botella A, Florence E, Lynen L, Colebunders R, Menten J, Moreno-Reyes R: Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther. 2010, 7: 40-10.1186\/1742-6405-7-40.","journal-title":"AIDS Res Ther"},{"key":"2511_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00002030-200303070-00006","volume":"17","author":"M Cozzolino","year":"2003","unstructured":"Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS: HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS. 2003, 17: 513-520. 10.1097\/00002030-200303070-00006.","journal-title":"AIDS"},{"key":"2511_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-6405-6-4","volume":"6","author":"A Conesa-Botella","year":"2009","unstructured":"Conesa-Botella A, Mathieu C, Colebunders R, et al: Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?. AIDS Res Ther. 2009, 6: 4-10.1186\/1742-6405-6-4.","journal-title":"AIDS Res Ther"},{"key":"2511_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3851\/IMP1502","volume":"15","author":"TT Brown","year":"2010","unstructured":"Brown TT, McComsey GA: Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther. 2010, 15: 425-429. 10.3851\/IMP1502.","journal-title":"Antivir Ther"},{"key":"2511_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1172\/JCI21867","volume":"115","author":"JM Pascussi","year":"2005","unstructured":"Pascussi JM, Robert A, Nguyen M, et al: Possible involvement of pregnane X receptorenhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest. 2005, 115: 177-186.","journal-title":"J Clin Invest"},{"key":"2511_CR37","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.07310.x","volume":"73","author":"J Silver","year":"1999","unstructured":"Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T: Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int Suppl. 1999, 73: S2-S7.","journal-title":"Kidney Int Suppl"},{"key":"2511_CR38","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1097\/00002030-200207260-00019","volume":"16","author":"PJ Piliero","year":"2002","unstructured":"Piliero PJ, Gianoukakis AG: Ritonavir-associated hyperparathyroidism, osteopenia and bone pain. AIDS. 2002, 16: 1565-1566. 10.1097\/00002030-200207260-00019.","journal-title":"AIDS"},{"key":"2511_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jcp.1041280216","volume":"128","author":"JA Yee","year":"1986","unstructured":"Yee JA, Sutton JK, Shew RL, Olansky L: Parathyroid hormone stimulation of alkaline phosphatase activity in cultured neonatal mouse calvarial bone cells: involvement of cyclic AMP and calcium. J Cell Physiol. 1986, 128: 246-250. 10.1002\/jcp.1041280216.","journal-title":"J Cell Physiol"},{"key":"2511_CR40","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1210\/en.138.8.3085","volume":"138","author":"XP Yu","year":"1997","unstructured":"Yu XP, Chandrasekhar S: Parathyroid hormone (PTH 1\u201334) regulation of rat osteocalcin gene transcription. Endocrinology. 1997, 138: 3085-3092. 10.1210\/en.138.8.3085.","journal-title":"Endocrinology"},{"key":"2511_CR41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.74.5.1045","volume":"74","author":"C Grunfeld","year":"1992","unstructured":"Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection. J Clin Endocrinol Metab. 1992, 74: 1045-1052. 10.1210\/jc.74.5.1045.","journal-title":"J Clin Endocrinol Metab"},{"key":"2511_CR42","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/QAI.0b013e31804216cf","volume":"44","author":"JC Shlay","year":"2007","unstructured":"Shlay JC, Bartsch G, Peng G, et al: Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor based strategy. J Acquir Immune Defic Syndr. 2007, 44: 506-517. 10.1097\/QAI.0b013e31804216cf.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2511_CR43","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","volume":"17","author":"PW Mallon","year":"2003","unstructured":"Mallon PW, Miller J, Cooper DA, Carr A: Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS. 2003, 17: 971-979. 10.1097\/00002030-200305020-00005.","journal-title":"AIDS"},{"key":"2511_CR44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1086\/341489","volume":"35","author":"MP Dub\u00e9","year":"2002","unstructured":"Dub\u00e9 MP, Qian D, Edmondson-Melan\u00e7on H, et al: Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy. Clin Infect Dis. 2002, 35: 475-481. 10.1086\/341489.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-293\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T07:19:42Z","timestamp":1548227982000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-293","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,28]]},"article-number":"293"}}